Navigation Links
inVentiv Health Provides Updated Information on December 11th Investor Day
Date:12/3/2007

SOMERSET, N.J., Dec. 3 /PRNewswire-FirstCall/ -- inVentiv Health, Inc. (Nasdaq: VTIV) today provided updated information on its upcoming Investor Day, which will be held Tuesday, December 11th, 2007 in New York City. The event will be begin at 8:30 a.m., not 9:00 a.m. as announced earlier, and will conclude at noon, followed by lunch.

The agenda will include a business overview, presentations by the leaders of each of the four major divisions, and a look at inVentiv's growing focus on integrated services.

The event will be held at the offices of inVentiv's Chandler Chicco Agency (CCA) business unit, located at 450 West 15th Street, Suite #700 in New York City. Please go to http://selectsurvey.inventivcommunications.com/TakeSurvey.aspx?SurveyID=88K I95 6 to request an invitation. Those who do not have Internet access can call (732) 537-4804.

The meeting is open to analysts and investors and will be accessible by live audio webcast on inVentiv Health's website at http://www.inventivhealth.com/health/newsroom/webcasts.asp. Presentation slides also will be available for all participants and an archived version of the webcast will be available on inVentiv Health's website for one week following the presentation.

Webcast segments will include:

8:30 a.m. - 10:30 a.m. Overview and Divisional Presentations

11 a.m. - noon Integrated Opportunities, Summary and Discussion

To listen to the presentation live, please dial 800-358-8448 (Domestic) or 706-634-1367 (International). A replay of the call will be available immediately following the call through December 18, 2007 at 800-642-1687 (Domestic) or 706-645-9291 (International). The conference ID number for the replay is 23949575.

About inVentiv Health

inVentiv Health, Inc. (Nasdaq: VTIV) is an insights-driven global healthcare leader that provides dynamic solutions to deliver customer and patient success. inVentiv delivers its customized clinical, sales, marketing and communications solutions through its four core business segments: inVentiv Clinical, inVentiv Communications, inVentiv Commercial, and inVentiv Patient Outcomes. inVentiv Health's client roster is comprised of more than 275 leading pharmaceutical, biotech, life sciences and healthcare payor companies, including all top 20 global pharmaceutical manufacturers. For more information, visit http://www.inventivhealth.com.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks that may cause inVentiv Health's performance to differ materially. Such risks include, without limitation: changes in trends in the pharmaceutical industry or in pharmaceutical outsourcing; our ability to compete successfully with other services in the market; our ability to maintain large client contracts or to enter into new contracts; uncertainties related to future incentive payments; and, our ability to operate successfully in new lines of business. Readers of this press release are referred to documents filed from time to time by inVentiv Health Inc. with the Securities and Exchange Commission for further discussion of these and other factors.


'/>"/>
SOURCE inVentiv Health, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
2. inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes
3. inVentiv Health to Announce Third Quarter Results and Conduct Conference Call on Wednesday, November 7, 2007
4. inVentiv Health to Present at the 2007 Credit Suisse Healthcare Conference
5. inVentiv Health Creates Client Development and Integration Team
6. Penn study finds pro-death proteins required to regulate healthy immune function
7. UCLA researchers identify markers that may predict diabetes in still-healthy people
8. Air pollution linked to cardiovascular risk indices in healthy young adults
9. More proof needed of safety and quality of electronic personal health records
10. Health care incentive model offers collaborative approach
11. Loneliness is bad for your health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... ... CloudLIMS, joins an elite number of companies that have earned a spot on ... CIOReview. , In a deliberate session with the honorary industrial experts, a list of ... with. The positioning is based on evaluation of CloudLIMS’ specialties in Automated Sample Management ...
(Date:5/25/2016)... ... 25, 2016 , ... DKT International, one of the largest ... pleased to release their 2015 global impact data. In 2015, DKT served over ... deaths and 3.8 million unsafe abortions across 21 countries worldwide. , “We ...
(Date:5/25/2016)... Mexico (PRWEB) , ... May 25, 2016 , ... Casa ... the restorative properties of precious stones to complement its new wellness suites . ... two floors and feature a plethora of special services and insuite amenities, from a ...
(Date:5/25/2016)... ... ... more than fifty years, we've suffered whiplash as each new scientific study seemed to contradict ... nutritional advice – advice that was supposed to keep us healthy and slim. And what ... are considered to be overweight and more than 1 in 3 adults are considered to ...
(Date:5/25/2016)... ... 25, 2016 , ... Researchers from SUNY State College of Optometry won the ... visual evoked potential and human attention. The article, VEP and Human Attention: Translation ... ERG and VEP Vision Testing System (Diopsys, Inc., Pine Brook, NJ) to record ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)...   , Study met both ... in , Excellent plus Good ... of the ascending colon   ,      ... announced new positive data from the phase III MORA study for ... litre PEG with ascorbate. The study met both primary endpoints showing ...
(Date:5/24/2016)... 2016 ARANZ Medical  Ltd a ... sector, has been named the Coretex Hi-Tech Emerging Company of ... Dr Bruce Davey , CEO of ARANZ Medical ... really good to be recognised for the work we are ... used in 35 countries around the world from Sub-Saharan Africa ...
(Date:5/24/2016)... 2016 Celsion Corporation (NASDAQ: ... provided an update on its ongoing OVATION study, ... GEN-1, the Company,s DNA-based immunotherapy, with the standard ... with advanced ovarian cancer who will undergo neoadjuvant ... an IL-12 DNA plasmid vector formulated as a ...
Breaking Medicine Technology: